Showing 1 - 6 results of 6 for search 'Goda Vaitkevičienė', query time: 0.03s Refine Results
  1. 1
    Cure rates of childhood acute lymphoblastic leukemia in Lithuania and the benefit of joining international treatment protocol

    Cure rates of childhood acute lymphoblastic leukemia in Lithuania and the benefit of joining international treatment protocol by Goda Vaitkevičienė, Rėda Matuzevičienė, Mindaugas Stoškus, Tadas Žvirblis, Lina Ragelienė, Kjeld Schmiegelow

    Published 2014-01-01
    Get full text
    Article
  2. 2
    Unilateral Hydronephrosis and Renal Damage after Acute Leukemia

    Unilateral Hydronephrosis and Renal Damage after Acute Leukemia by Egle Simanauskiene, Valentina Daugelaviciene, Arvydas Laurinavicius, Ugnius Mickys, Vaida Simonyte, Goda Vaitkeviciene, Gilvydas Verkauskas

    Published 2012-01-01
    Get full text
    Article
  3. 3
    PB1706: ABL-CLASS GENOMIC BREAKPOINT Q-PCR FOR RELIABLE MEASURABLE RESIDUAL DISEASE MONITORING IN ALL PATIENTS

    PB1706: ABL-CLASS GENOMIC BREAKPOINT Q-PCR FOR RELIABLE MEASURABLE RESIDUAL DISEASE MONITORING IN ALL PATIENTS by Inge van Outersterp, Vincent van der Velden, Patricia Hoogeveen, Goda Vaitkevičienė, Gijs van Haaften, Roland Kuiper, Udo Zur Stadt, Judith M. Boer, Monique den Boer

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Impact of age and sex on survival outcomes in patients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial

    Impact of age and sex on survival outcomes in patients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial by Tuomas Lahteenmaki Taalas, Trausti Oskarsson, Mats Heyman, Bendik Lund, Kristi Lepik, Goda Vaitkevičiene, Olafur Gisli Jonsson, Julia Eriksson, Nina Toft, Laimonas Griškevičius, Helene Hallbook, Katrin Palk, Ulla Wartiovaara-Kautto, Petter Quist-Paulsen, Ulrika Noren-Nystrom, Kim Vettenranta, Jonas Abrahamsson, Kjeld Schmiegelow, Paivi M Lahteenmaki

    Published 2025-02-01
    Get full text
    Article
  5. 5
    Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes

    Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes by Stavroula Anastasopoulou, Rikke Linnemann Nielsen, Bodil Als-Nielsen, Joanna Banerjee, Mats A. Eriksson, Marianne Helenius, Mats M. Heyman, Inga Maria Johannsdottir, Olafur Gisli Jonsson, Stuart MacGregor, Marion K. Mateos, Chelsea Mayoh, Sirje Mikkel, Ida Hed Myrberg, Riitta Niinimäki, Kjeld Schmiegelow, Mervi Taskinen, Goda Vaitkeviciene, Anna Warnqvist, Benjamin Wolthers, Arja Harila-Saari, Susanna Ranta

    Published 2022-03-01
    Get full text
    Article
  6. 6
    Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0–45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol

    Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-me... by Linea Natalie Toksvang, Bodil Als-Nielsen, Christopher Bacon, Ruta Bertasiute, Ximo Duarte, Gabriele Escherich, Elín Anna Helgadottir, Inga Rinvoll Johannsdottir, Ólafur G. Jónsson, Piotr Kozlowski, Cecilia Langenskjöld, Kristi Lepik, Riitta Niinimäki, Ulrik Malthe Overgaard, Mari Punab, Riikka Räty, Heidi Segers, Inge van der Sluis, Owen Patrick Smith, Marion Strullu, Goda Vaitkevičienė, Hilde Skuterud Wik, Mats Heyman, Kjeld Schmiegelow

    Published 2022-05-01
    Get full text
    Article

Search Tools: